Endometrial cancer

One of the most common gynecologic cancers, endometrial cancer is often identified early when patients present with postmenopausal bleeding. Although outcomes ...

“There is a lot of enthusiasm around innovating and developing personalized therapies that are more effective for patients,” Amarnath said. No endometrial cancer–related deaths after 3 years were reported in patients with FIGO stage IA nonendometrioid endometrial cancer without myometrial invasion.1 A recent retrospective study by Mariam AlHilli, MD, found that patients in International Federation of Gynecology and Obstetrics (FIGO) stage I high- intermediate risk subgroups with fewer than 2 risk factors (FIGO grade 2 or 3, lympho-vascular space invasion [LVSI], or stage IB) had a greater than 95% cause-specific survival at 3-year follow-up and subgroups with 2 or more risk factors had poorer outcomes.